Details Consolidated financial statements for the period ended 30 September 2024Consolidated Financial Statements resultsBy Rameda Adminنوفمبر 14, 2024
Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical Market Corporate NewsBy Rameda Adminسبتمبر 9, 2024
Details Standalone financial statements for the period ended 30 June 2024Results Center, Standalone Financial StatementsBy Rameda Adminأغسطس 13, 2024
Details Consolidated financial statements for the period ended 30 June 2024Consolidated Financial Statements results, Results CenterBy Rameda Adminأغسطس 13, 2024
Rameda Announces Price Increase Approvals for All Its Top Products Corporate NewsBy Rameda Adminأغسطس 7, 2024
Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance Corporate NewsBy Rameda Adminمايو 28, 2024
